UBS/CALL/SONOVA HLDG N/300.005/0.02/20.09.24 | Market Closed - Swiss Exchange 11:20:00 2024-05-31 am EDT | ||
| 0.19 CHF | -5.00% |
|
| 3 months | -5.00% | ||
| 6 months | +46.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SONOVA HOLDING AG
Latest news about SONOVA HOLDING AG
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.19 | -5.00% |
| 24-05-30 | 0.2 | -4.76% |
| 24-05-28 | 0.21 | -8.70% |
| 24-05-27 | 0.23 | -14.81% |
| 24-05-24 | 0.27 | -3.57% |
Delayed Quote Swiss Exchange
Last update May 31, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | SONOVA HOLDING AG |
| Issuer | UBS |
| PSOOQU | |
| ISIN | CH1246587260 |
| Date issued | 2023-03-20 |
| Strike | 300 CHF |
| Maturity | 2024-09-20 (111 Days) |
| Parity | 50 : 1 |
| Emission price | 0.32 CHF |
| Emission volume | N/A |
| Settlement | physical |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.69 CHF |
|---|---|
| Lowest since issue | 0.05 CHF |
| Spread | 0.01 CHF |
| Spread % | 5.26% |
Company Profile
Sonova Holding AG is the world's leading provider of innovative hearing solutions. Its broad product portfolio includes traditional hearing aids, cochlear implants and wireless communication systems. Net sales break down by family of products as follows:
- hearing aids (92.3%);
- cochlear implants (7.7%).
The geographical breakdown of sales is as follows: Switzerland (1.2%%), Europe/Middle East/Africa (48.8%), the United States (30.8%), the Americas (7.3%) and Asia/Pacific (11.9%).
Sector
-
Consensus: Sonova Holding AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
284.8
CHF
Average target price
279.1
CHF
Spread / Average Target
-2.00%
- Stock Market
- Warrants
- PSOOQU Warrant
